Skip to main content
. 2017 May 11;116(12):1564–1571. doi: 10.1038/bjc.2017.125

Table 3. Association of identified mutations with clinicopathologic features.

  Mutations not identified (n=39) Mutations identified (n=27)  
Characteristic N (%)a N (%)a P-value
Age (mean±s.d.) 65.2±12.6 years 61.3±13.4 years 0.23
Sex     0.20
 Female 17 (44%) 16 (59%)  
 Male 22 (56%) 11 (41%)  
Smoking     0.14
 Current/former 19 (49%) 9 (33%)  
 Never 20 (51%) 18 (67%)  
Site     0.09
 Nasal cavity 34 (87%) 8 (30%)  
 Paranasal sinuses 5 (13%) 19 (70%)  
T classification     0.76
 3 22 (56%) 13 (48%)  
 4a 13 (33%) 10 (37%)  
 4b 4 (10%) 4 (15%)  
N classification     0.36
 N0 36 (92%) 23 (85%)  
 N+ 3 (8%) 4 (15%)  
Mitosis rate     0.01
 <1 27 (69%) 10 (37%)  
 ⩾1 12 (31%) 17 (63%)  
Ulceration     0.59
 Present 27 (69%) 17 (63%)  
 Absent 12 (31%) 10 (37%)  
Cell morphology     0.43
 Pagetoid 8 (21%) 6 (22%)  
 Epithelioid 7 (18%) 7 (25%)  
 Spindled 7 (18%) 9 (33%)  
 Rhabdoid 8 (21%) 4 (15%)  
 Undifferentiated (small cell) 13 (33%) 9 (33%)  
Bone invasion     0.35
 Absent 33 (85%) 20 (74%)  
 Present 6 (15%) 7 (26%)  
Treatment     0.88
 Surgery 18 (46%) 12 (44%)  
 Surgery and radiation 18 (46%) 12 (44%)  
 Surgery and chemoradiation 3 (8%) 3 (12%)  
a

Unless otherwise indicated.